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Objectives
Recent studies have shown that interleukin-23 receptor
(IL23R) polymorphisms confer susceptibility to ankylos-
ing spondylitis, psoriasis, psoriatic arthritis and Crohn’s
disease. The A allele of rs1004819 was found in a signif-
icantly higher frequency among patients suffering from
these diseases compared to controls. We aimed to deter-
mine the affect of rs1004819 in M694V homozygote
FMF patients.
Methods
We typed 59 M694V homozygote FMF patients for the
rs1004819 polymorphism, 27 of whom were defined as
non responders to colchicine treatment. In addition we
typed 57 ethnically matched controls.
Results
We found an over representation of the A allele in the
non responders (A-29, G-25) as compared to the con-
trols (A-33, G-77) (p=0.01), while a similar frequency
was found between the responders (A-24, G-40) and the
controls (p= 0.3).
Conclusions
These results suggest that IL23 and its pathways are
involved in the FMF inflammatory response. This asso-
ciation may provide new insights and treatment possibili-
ties for FMF patients who do not respond to colchicine.
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